The APhA Complete Review for Pharmacy - Couverture souple

Couverture souple

ISBN 10 : 1582121621 ISBN 13 : 9781582121628

Editeur : American Pharmacists Association, 2012

Synopsis

The NAPLEX[registered] (North American Pharmacist Licensure Examination[registered]) is the standard licensing exam that all U.S. pharmacy students must pass to practice pharmacy. It's an arduous exam that tests a daunting range of knowledge. Approximately 10 per cent of students taking the exam for the first time fail to achieve a passing score. Preparing for the NAPLEX[registered] by reviewing all of the material from each pharmacy school course would be overwhelming. A far better approach would be to study only the information most relevant to the exam, summarized in abbreviated bullet format - and that's what ""The APhA Complete Review for Pharmacy"" contains.Features of this title include: Top 200 drugs: Begin your NAPLEX[registered] preparation by learning the generic and trade names for the top 200 drugs; Math: After generic and trade names, this is the most important single area to review; Drug therapy for chronic and common diseases: This is the heart of today's NAPLEX and the subject of more than half of the 40 chapters in this study guide; and, Summary tables of the major drug categories: Drug charts, including dosage schedules and dosage forms, are provided in each of the therapeutic chapters. New to this edition are three new chapters - Drug Information, Biostatistics, and Clinical Trial Design. An updated chapter on new drug approvals, indications, and formulations is also included. This title includes review questions. All chapters end with 20 or more practice exam questions and answers as well as explanation that reinforce key learning points.

Détails de l'édition

• Éditeur: American Pharmacists Association
• Date d'édition: 2012
• Langue: anglais
• ISBN 10: 1582121621
• ISBN 13: 9781582121628
• Reliure: Broché
• Nombre de pages: 964
• Éditeur: Gourley Dick R., Eoff James C.
• Coordonnées du fabricant: non disponible
• Personne responsable: non disponible